Residency · Rochester, NY
Sponsored by University of Rochester Medicine
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
MMWR. Morbidity and mortality weekly report · 2024 · 183 citations · Geoffrey Weinberg
Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes.
Nature · 2023 · 372 citations · Jennifer Anolik
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.
JAMA pediatrics · 2025 · 64 citations · Geoffrey Weinberg
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
Allergy · 2023 · 130 citations · Gerald Gleich
Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children.
JAMA pediatrics · 2026 · 25 citations · Geoffrey Weinberg
Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024.
MMWR. Morbidity and mortality weekly report · 2024 · 74 citations ·
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025.
MMWR. Morbidity and mortality weekly report · 2025 · 54 citations · Geoffrey Weinberg
Granzyme K+ CD8 T cells form a core population in inflamed human tissue.
Science translational medicine · 2022 · 251 citations · Jennifer Anolik